Bay Area Tumor Institute CCOP

描述(由申请人提供)：湾区肿瘤研究所社区临床肿瘤学项目(BATI-CCOP)是由加利福尼亚州大奥克兰的7家社区和县医院组成的联盟。自1979年作为CGOP成立并于1989年成为CCOP以来，该联盟一直为社区的癌症专家、初级保健医生和医院提供NCI批准和资助的临床试验计划。结合卫生部出版物“2010年健康人群”的目标，以阿拉米达县及其主要城市奥克兰的少数民族、低收入和女性人口为目标，BATI-CCOP使癌症患者和普通“高危”人群能够参与SWOG、NSABP、RTOG、COG、HLMCC和CCCWFU的临床和癌症控制研究。在其成就的基础上，BATI-CCOP的长期目标和具体目标包括以高于可比CCOP的比率获得治疗试验的应计利润，以高于所有其他CCOP的比率获得少数族裔和儿科患者的应计费用，积极招募癌症控制人员和超过NCI癌症控制研究要求的应计费用，加强与研究基地的互动，以及继续履行NCI的“条款和条件”。CCOP将继续吸纳该地区95%的符合条件的儿科肿瘤患者，并将继续在招募基本上符合少数群体CCOP、儿科CCOP和成人CCOP要求的少数族裔和女性参与者方面表现出色。CCOP还将继续超过NCI的授权，并保持旧金山湾区癌症预防和控制试验收益的领先地位。BATI-CCOP提供了成功的长期记录、有组织和坚定的医疗界、经验丰富的医生调查人员、旧金山湾区肿瘤研究所的机构和资金支持，以及接触非裔美国人、西班牙裔、亚洲人、儿科、服务不足和女性人口的独特机会。

DESCRIPTION (provided by applicant): The Bay Area Tumor Institute Community Clinical Oncology Program (BATI-CCOP) is a consortium of 7 community and county hospitals in Greater Oakland, California. Since its creation in 1979 as a CGOP and its convention to CCOP status in 1989, this consortium has continuously provided the community's cancer specialists, primary care physicians, and hospitals with an NCI-approved and funded clinical trials program. Integrating the goals of DHHS publication "Healthy People 2010" by targeting minority, low income and female populations in Alameda County and its main city, Oakland, the BATI-CCOP enables cancer patients and the general "at risk" population to participate in clinical and cancer control research of SWOG, NSABP, RTOG, COG, HLMCC and CCCWFU. Building on its achievements, the long-term objectives and specific aims of the BATI-CCOP include accrual to therapeutic trials at higher rates than comparable CCOPs, accrual of minority and pediatric patients at higher rates than all other CCOPs, aggressive cancer control recruitment and accrual exceeding NCI's cancer control research reequirements, increased interaction with research bases, and continued fulfillment of NCI's "Terms and Conditions". The CCOP will continue to accrue 95% of all eligible pediatric oncology patients in the region and will continue to excel in the recruitment of minority and female participants essentially meeting the requirements of a Minority-Based CCOP, a Pediatric CCOP and an Adult CCOP. The CCOP will also continue to exceed NCI mandates and remain the Bay Area leader in accrual to cancer prevention and control trials. The BATI-CCOP offers a successful long-term track record, an organized and committed medical community, experienced physician investigators, institutional and financial support from the Bay Area Tumor Institute, and unusual access to African American, Hispanic, Asian, pediatric, underserved, and female populations.